Search by Drug Name or NDC

    NDC 58809-0187-08 VANACOF XP Cough / Chest Congestion 18; 396 mg/15mL; mg/15mL Details

    VANACOF XP Cough / Chest Congestion 18; 396 mg/15mL; mg/15mL

    VANACOF XP Cough / Chest Congestion is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by GM Pharmaceuticals, INC. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.

    Product Information

    NDC 58809-0187
    Product ID 58809-187_0c040c32-811e-87b0-e063-6294a90a6255
    Associated GPIs
    GCN Sequence Number 085632
    GCN Sequence Number Description guaifenesin/dextromethorphan LIQUID 396-18/15 ORAL
    HIC3 B3T
    HIC3 Description NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION
    GCN 55095
    HICL Sequence Number 000223
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR
    Brand/Generic Brand
    Proprietary Name VANACOF XP Cough / Chest Congestion
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextromethorphan HBr, Guaifenesin
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 18; 396
    Active Ingredient Units mg/15mL; mg/15mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
    Labeler Name GM Pharmaceuticals, INC
    Pharmaceutical Class Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 58809-0187-08 (58809018708)

    NDC Package Code 58809-187-08
    Billing NDC 58809018708
    Package 1 mL in 1 BOTTLE (58809-187-08)
    Marketing Start Date 2023-12-06
    NDC Exclude Flag N
    Pricing Information N/A